• Day 2 Highlights from ASH 2024: Smoldering Myeloma, CLL Advances, and Ground Zero Insights

  • 2024/12/09
  • 再生時間: 6 分
  • ポッドキャスト

Day 2 Highlights from ASH 2024: Smoldering Myeloma, CLL Advances, and Ground Zero Insights

  • サマリー

  • On Day 2 of ASH 2024, we explore breakthroughs in treating high-risk smoldering multiple myeloma, advancements in chronic lymphocytic leukemia therapies, and a revealing study on leukemia risk in Ground Zero first responders. Stay updated with insights that are reshaping hematology practice.

    Love what you hear? Download the Curie app for daily updates and bonus episodes tailored for oncology professionals.

    続きを読む 一部表示

あらすじ・解説

On Day 2 of ASH 2024, we explore breakthroughs in treating high-risk smoldering multiple myeloma, advancements in chronic lymphocytic leukemia therapies, and a revealing study on leukemia risk in Ground Zero first responders. Stay updated with insights that are reshaping hematology practice.

Love what you hear? Download the Curie app for daily updates and bonus episodes tailored for oncology professionals.

Day 2 Highlights from ASH 2024: Smoldering Myeloma, CLL Advances, and Ground Zero Insightsに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。